Tilray Brands Inc.

0.49
0.00 (0.53%)
At close: Apr 14, 2025, 3:59 PM
0.49
-0.25%
After-hours: Apr 14, 2025, 07:59 PM EDT
0.53%
Bid 0.47
Market Cap 490.57M
Revenue (ttm) 826.66M
Net Income (ttm) -945.62M
EPS (ttm) -1.1
PE Ratio (ttm) -0.44
Forward PE -30
Analyst Hold
Ask 0.49
Volume 28,541,344
Avg. Volume (20D) 39,556,557
Open 0.49
Previous Close 0.49
Day's Range 0.46 - 0.49
52-Week Range 0.44 - 2.52
Beta 1.99

About TLRY

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils,...

Sector Healthcare
IPO Date Jul 19, 2018
Employees 2,650
Stock Exchange NASDAQ
Ticker Symbol TLRY
Full Company Profile

Analyst Forecast

According to 3 analyst ratings, the average rating for TLRY stock is "Hold." The 12-month stock price forecast is $1.38, which is an increase of 183.14% from the latest price.

Stock Forecasts

Earnings Surprise

Tilray Brands has released their quartely earnings on Apr 8, 2025:
  • Revenue of $185.78M misses estimates by $24.67M, with -1.36% YoY decline.
  • EPS of 0 exceeds estimates by 0.03, with n/a YoY .
  • Next Earnings Release

    Tilray Brands Inc. is scheduled to release its earnings on Jul 28, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 week ago
    -21.23%
    Tilray Brands shares are trading lower after the c... Unlock content with Pro Subscription
    2 weeks ago
    +8.97%
    Tilray Brands shares are trading higher after it and its subsidiary HEXO Corporation announced the dismissal of a lawsuit filed by Clement Italume.